Federica Mangili

7PUBLICATIONS
34CO-AUTHORS
PharmacogenomicsPredictive and prognostic markersSolid tumoursCancer cell biologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 19, 2026
Characterization of SF3B1 role in prolactin-secreting pituitary tumors.

|Jun 15, 2026
Prevalence of somatic SF3B1R625H mutation in lactotroph tumours from a multi-centric cohort: a digital PCR-based study.

|Feb 13, 2026
Biological targets and therapeutic strategies in the treatment of non-functioning pituitary tumors: state-of-the-art.

Federica Mangili, Donatella Treppiedi, Genesio Di Muro

|Jul 12, 2023
Role of filamin A in the pathogenesis of neuroendocrine tumors and adrenal cancer.

Donatella Treppiedi, Rosa Catalano, Federica Mangili

|Jun 28, 2023
A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells.

Genesio Di Muro, Federica Mangili, Emanuela Esposito

|May 28, 2022
P720R USP8 Mutation Is Associated with a Better Responsiveness to Pasireotide in ACTH-Secreting PitNETs.

Donatella Treppiedi, Giusy Marra, Genesio Di Muro

Pageof 2

Frequent Collaborators

6 joint publications

Erika Peverelli

4 joint publications

Anna Maria Barbieri

3 joint publications

Maura Arosio

3 joint publications

Giovanna Mantovani